Guido Cavaletti

25.0k total citations · 3 hit papers
364 papers, 15.8k citations indexed

About

Guido Cavaletti is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Guido Cavaletti has authored 364 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Oncology, 82 papers in Hematology and 67 papers in Molecular Biology. Recurrent topics in Guido Cavaletti's work include Cancer Treatment and Pharmacology (193 papers), Multiple Myeloma Research and Treatments (76 papers) and Glioma Diagnosis and Treatment (58 papers). Guido Cavaletti is often cited by papers focused on Cancer Treatment and Pharmacology (193 papers), Multiple Myeloma Research and Treatments (76 papers) and Glioma Diagnosis and Treatment (58 papers). Guido Cavaletti collaborates with scholars based in Italy, United States and Spain. Guido Cavaletti's co-authors include P Marmiroli, G Tredici, Andreas A. Argyriou, Paola Alberti, Jordi Bruna, N Oggioni, A Canta, Valentina Carozzi, Anthony J. Windebank and A Chiorazzi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Guido Cavaletti

353 papers receiving 15.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

2014 887 citations Guido Cavaletti, Maryam B. Lustberg et al. profile →
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

2020 615 citations Guido Cavaletti, Maryam B. Lustberg et al. profile →
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

2011 431 citations Andreas A. Argyriou, P Marmiroli et al. Critical Reviews in Oncology/Hematology profile →

Peers

Countries citing papers authored by Guido Cavaletti

Since Specialization

Citations

This map shows the geographic impact of Guido Cavaletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Cavaletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Cavaletti more than expected).

Fields of papers citing papers by Guido Cavaletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Cavaletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Cavaletti. The network helps show where Guido Cavaletti may publish in the future.

Co-authorship network of co-authors of Guido Cavaletti

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Cavaletti. A scholar is included among the top collaborators of Guido Cavaletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Cavaletti. Guido Cavaletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 2025 ·Toxics ·Guido Cavaletti, A Canta, A Chiorazzi, E Pozzi, Valentina Carozzi, C Meregalli, Paola Alberti, P Marmiroli, Arianna Scuteri, Luca Crippa, Silvia Fermi, (unknown), Barbara Vergani, Christian Steinkühler, Simonetta Andrea Licandro	1
2	Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 2023 ·International Journal of Molecular Sciences ·Alessio Malacrida, (unknown), R Rigolio, Guido Cavaletti, Mariarosaria Miloso	4
3	Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 2023 ·Toxics ·E Pozzi, E Ballarini, Virginia Rodriguez‐Menendez, A Canta, A Chiorazzi, L Monza, M Bossi, Paola Alberti, Alessio Malacrida, C Meregalli, Arianna Scuteri, Guido Cavaletti, Valentina Carozzi	7
4	Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 2023 ·Journal of the Peripheral Nervous System ·(unknown), A Canta, A Chiorazzi, Valentina Carozzi, C Meregalli, E Pozzi, Paola Alberti, (unknown), Daan R. van der Veen, P Marmiroli, Debra J. Skene, Guido Cavaletti	2
5	Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 2023 ·International Journal of Molecular Sciences ·E Pozzi, L Monza, E Ballarini, M Bossi, Virginia Rodriguez‐Menendez, A Canta, A Chiorazzi, Valentina Carozzi, Luca Crippa, P Marmiroli, Guido Cavaletti, Paola Alberti	3
6	Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria 2022 ·Cells ·Paola Alberti, (unknown), Guido Cavaletti, Arianna Scuteri	21
7	HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity? 2022 ·Cancers ·(unknown), Arianna Scuteri, Guido Cavaletti	6
8	Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 2022 ·Biomedicines ·A Canta, Valentina Carozzi, A Chiorazzi, C Meregalli, N Oggioni, Virginia Rodriguez‐Menendez, (unknown), Roberto Cosimo Melcangi, Silvia Giatti, Raffaella Lombardi, Roberto Bianchi, P Marmiroli, Guido Cavaletti	0
9	Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 2022 ·International Journal of Molecular Sciences ·(unknown), E Ballarini, E Donzelli, Virginia Rodriguez‐Menendez, M Bossi, Guido Cavaletti, Arianna Scuteri	7
10	Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 2022 ·International Journal of Molecular Sciences ·E Ballarini, Alessio Malacrida, Virginia Rodriguez‐Menendez, E Pozzi, A Canta, A Chiorazzi, L Monza, (unknown), C Meregalli, Valentina Carozzi, (unknown), Gabriella Nicolini, Arianna Scuteri, Stephen N. Housley, Guido Cavaletti, Paola Alberti	14
11	Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M) 2022 ·JNCI Cancer Spectrum ·Per Pfeiffer, Maryam B. Lustberg, (unknown), Stefan Carlsson, Anders Persson, (unknown), Guido Cavaletti, Bengt Glimelius, Kei Muro	12
12	Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 2021 ·Proceedings of the National Academy of Sciences ·Maria Elena Pero, C Meregalli, Xiaoyi Qu, (unknown), Atul Kumar, Matthew Shorey, Melissa M. Rolls, Kurenai Tanji, Thomas H. Brannagan, Paola Alberti, G Fumagalli, L Monza, Wesley B. Grueber, Guido Cavaletti, Francesca Bartolini	29
13	Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: Systematic review and evidence-based recommendations 2021 ·Critical Reviews in Oncology/Hematology ·Stefano Tamburin, Susanna B. Park, Angelo Schenone, Elisa Mantovani, (unknown), Paola Alberti, (unknown), Ian R. Kleckner, Noah Kolb, (unknown), Brendan McNeish, Andreas A. Argyriou, Guido Cavaletti, Ahmet Höke	34
14	Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study 2019 ·Endocrine Connections ·Roberto Cosimo Melcangi, Livio Casarini, Marco Marino, Daniele Santi, Samantha Sperduti, Silvia Giatti, Silvia Diviccaro, Maria Grazia Grimoldi, Donatella Caruso, Guido Cavaletti, Manuela Simoni	13
15	Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment 2019 ·Journal of the Peripheral Nervous System ·Nathan P. Staff, Guido Cavaletti, (unknown), Maryam B. Lustberg, Dimitri Psimaras, Stefano Tamburin	102
16	The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 2018 ·Orphanet Journal of Rare Diseases ·Anna Ambrosini, Daniela Calabrese, (unknown), (unknown), Guido Cavaletti, Maria Carmela Pera, António Toscano, Giuseppe Vita, Lucía Monaco, Davide Pareyson	24
17	Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 2012 ·BOA (University of Milano-Bicocca) ·Guido Cavaletti, (unknown), (unknown), (unknown), Solange Andreoni, Fabrizio Piazza	1
18	Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice 2011 ·Cancer Research ·Krystyna M. Wozniak, K. Nomoto, Rena G. Lapidus, Ying Wu, Valentina Carozzi, Guido Cavaletti, Kazuhiro Hayakawa, Satoru Hosokawa, Murray J. Towle, Bruce A. Littlefield, Barbara S. Slusher	75
19	CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 2010 ·Journal of the Peripheral Nervous System ·(unknown), A Canta, N Oggioni, Giovanni Battista La Sala, C Meregalli, A Chiorazzi, E Ballarini, Guido Cavaletti	1
20	Neurotoxicity of oxaliplatin (I-OHP) in rats and influence of scheduling 2000 ·Clinical Cancer Research ·Guido Cavaletti, G Tredici, M G Petruccioli, (unknown), P Tredici, P Marmiroli, Carla Minoia, (unknown), M. Bayssas, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact